XML 47 R35.htm IDEA: XBRL DOCUMENT
v3.23.2

Collaboration and License Agreement - Schedule of Transaction Price Performance Obligations (Details) $ in Thousands | Jun. 30, 2023 USD ($)
--- | ---
Roche |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Transaction price | $ 138,626
Roche | Combined licenses |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Transaction price | 105,327
Roche | Completion of Continuing Trials |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Transaction price | 30,585
Roche | Transfer of clinical trial materials |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Transaction price | 2,714
Bristol-Myers Squibb Company |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Transaction price | 50,000
Bristol-Myers Squibb Company | Research Activities |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Transaction price | 6,405
Bristol-Myers Squibb Company | Options to License Druggable Target Lesions |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Transaction price | 31,148
Bristol-Myers Squibb Company | Options to License Undruggable Targets |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Transaction price | $ 12,447

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2 + Details
Name: | us-gaap_ContractWithCustomerLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | dei_LegalEntityAxis=rptx_HoffmannLaRocheIncAndFHoffmannLaRocheLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=rptx_CombinedLicensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=rptx_CompletionOfContinuingTrialsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=rptx_TransferOfClinicalTrialMaterialsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=rptx_BristolMyersSquibbCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=rptx_ResearchActivitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=rptx_OptionToLicenseDruggableTargetLesionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=rptx_OptionsToLicenseUndruggableTargetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |